Literature DB >> 8624195

Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy.

R D Hurst1, M Molinari, T P Chung, M Rubin, F Michelassi.   

Abstract

OBJECTIVE: To determine the incidence timing and effectiveness of treatment of symptomatic pouchitis following restorative proctocolectomy with ileal J-pouch anal anastomosis.
DESIGN: A cohort analytical study.
SETTING: University hospitals, a tertiary referral center; all subjects entered into the study followed up for a minimum of 12 months (mean follow-up, 40 months). PATIENTS: One hundred four consecutive patients undergoing restorative proctocolectomy with ileal J-pouch anal anastomosis for either ulcerative colitis (n = 97) or familial adenomatous polyposis (n = 7) between June 1986 and December 1994.
INTERVENTIONS: Patients with symptomatic pouchitis were treated with either oral metronidazole or ciprofloxacin. OUTCOMES: Diagnosis of pouchitis was determined by clinical symptoms and confirmed with endoscopy. Response to oral antibodies was determined by resolution of symptoms.
RESULTS: Fifty-two patients (50%) experience at lest 1 episode of pouchitis. The first episode of pouchitis occurred within the first 12 months after restoration of intestinal continuity in 56% of the cases. In 2 patients it occurred after 30 months. Response to antibiotic treatment was 96%. Two thirds of patients had multiple episodes. Chronic pouchitis occurred in 6 patients, necessitating pouch removal in 2.
CONCLUSIONS: The incidence of pouchitis after ileal J-pouch anal anastomosis is approximately 50% with two thirds of these patients having multiple episodes. Chronic pouchitis occurs in a minority of patients. In chronic pouchitis, the risk of pouch loss is substantial.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624195     DOI: 10.1001/archsurg.1996.01430170043007

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  59 in total

1.  Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitis.

Authors:  T Kühbacher; P Gionchetti; J Hampe; U Helwig; P Rosenstiel; M Campieri; H J Buhr; S Schreiber
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

2.  Intestinal stasis associated bowel inflammation.

Authors:  Shunichiro Komatsu; Yuji Nimura; D Neil Granger
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

Review 3.  Medical management of postoperative complications of inflammatory bowel disease: pouchitis and Crohn's disease recurrence.

Authors:  J P Achkar; B Shen
Journal:  Curr Gastroenterol Rep       Date:  2001-12

4.  Fulminant Ulcerative Colitis.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-06

Review 5.  Optimization of conventional therapy in patients with IBD.

Authors:  Kirstin M Taylor; Peter M Irving
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-04       Impact factor: 46.802

Review 6.  Diagnosis and management of pouchitis and ileoanal pouch dysfunction.

Authors:  Udayakumar Navaneethan; Bo Shen
Journal:  Curr Gastroenterol Rep       Date:  2010-12

7.  Diagnosis and treatment of ileal pouch diseases in patients with underlying ulcerative colitis.

Authors:  Bo Shen; Bret Lashner
Journal:  Curr Treat Options Gastroenterol       Date:  2006-02

Review 8.  Antibiotics and probiotics in treatment of inflammatory bowel disease.

Authors:  Paolo Gionchetti; Fernando Rizzello; Karen-M Lammers; Claudia Morselli; Lucia Sollazzi; Samuel Davies; Rosy Tambasco; Carlo Calabrese; Massimo Campieri
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

9.  Chronic pouchitis after ileal pouch-anal anastomosis for ulcerative colitis: effect on quality of life.

Authors:  Matthias Turina; Connie J Pennington; Jennifer Kimberling; Arnold J Stromberg; Robert E Petras; Susan Galandiuk
Journal:  J Gastrointest Surg       Date:  2006-04       Impact factor: 3.452

10.  High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis.

Authors:  P R Fleshner; E A Vasiliauskas; L Y Kam; N E Fleshner; J Gaiennie; M T Abreu-Martin; S R Targan
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.